| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44901 | |||
| Azide and BSA Free | NBP2-34594-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54625-0.025mg | |||
F0101B). Quadrant markers were set based on control antibody staining (Catalog # MAB003)." alt="HEK293 human embryonic kidney cell line transfected with either (A) human CEACAM-5/CD66e or (B) human CEACAM-8/CD66b and eGFP was stained with Mouse Anti-Human CEACAM-5/CD66e Monoclonal Antibody (Catalog # MAB41281) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B). Quadrant markers were set based on control antibody staining (Catalog # MAB003)." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70407 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85742-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54624-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-05767 | |||
| IHC-Prediluted | NBP3-05768 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44899 | |||
| Azide and BSA Free | NBP2-34586-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34851-0.1mg | |||
| IHC-Prediluted | NBP2-44896 | |||
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-CEA31-Immunohistochemistry-Paraffin-NBP2-33012-img0005.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-CEA31-Immunohistochemistry-Paraffin-NBP2-33012-img0003.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-CEA31-Immunohistochemistry-Paraffin-NBP2-33012-img0004.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Analysis of CEACAM5/CD66e antibody (CEA31) on Human Colon Carcinoma. Incubation: 1 ug/mL for 30 minutes at room temperature. Image from verified customer review.](http://images.novusbio.com/fullsize/nbp2-33012_mouse-monoclonal-ceacam5-cd66e-antibody-cea31-17720249362620.jpg)
![Western Blot: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Analysis of human granulocyte lysate: Detection using 10 ug/ml Anti-CEACAM5 [5C8C4] followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Western-Blot-NBP2-54625-img0008.jpg "Western Blot: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Analysis of human granulocyte lysate: Detection using 10 ug/ml Anti-CEACAM5 [5C8C4] followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.")
![Flow Cytometry: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM5 [5C8C4] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Flow-Cytometry-NBP2-54625-img0003.jpg)
![ELISA: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Solid phase was coated with 3 ug/ml Anti-CEA (Dako) binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM5/8 [5C8C4] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-ELISA-NBP2-54625-img0002.jpg)
![Immunoprecipitation: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Human granulocyte lysate: Utilizing 10 ug/ml Anti-CEACAM5/8 [5C8C4]. Detection of the sample using 5 ug/ml pAb Anti-CEA followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Immunoprecipitation-NBP2-54625-img0006.jpg)
VC001). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cell membranes. View our protocol for ![Immunohistochemistry-Paraffin: CEACAM-5/CD66e Antibody (CB30) [NB110-58734] - Human colorectal carcinoma](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-CB30-Immunohistochemistry-Paraffin-NB110-58734-img0002.jpg "Immunohistochemistry-Paraffin: CEACAM-5/CD66e Antibody (CB30) [NB110-58734] - Human colorectal carcinoma")
![Immunohistochemistry-Paraffin: CEACAM-5/CD66e Antibody (CB30) [NB110-58734] - Human colorectal carcinoma](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-CB30-Immunohistochemistry-Paraffin-NB110-58734-img0001.jpg)
![Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Western-Blot-NBP2-46231-img0018.jpg "Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.")
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0017.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0001.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0002.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0003.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0004.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0005.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0006.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0007.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0008.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0009.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0010.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0011.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0012.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0013.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0014.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0015.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0016.jpg)
![Western Blot: CEACAM5/CD66e Antibody [NBP1-85742] - Analysis in human colon tissue.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Western-Blot-NBP1-85742-img0005.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody [NBP1-85742] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Immunohistochemistry-Paraffin-NBP1-85742-img0013.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody [NBP1-85742] - Staining of human colorectal cancer shows strong membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Immunohistochemistry-Paraffin-NBP1-85742-img0011.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody [NBP1-85742] - Staining of human colon shows strong membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Immunohistochemistry-Paraffin-NBP1-85742-img0012.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody [NBP1-85742] - Staining of human pancreas shows no positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Immunohistochemistry-Paraffin-NBP1-85742-img0014.jpg)
![Western Blot: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Detection using 10 ug/ml Anti-CEACAM3/5 [308/3-3] followed by HRP-coupled secondary pAb. Visualized by chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Western-Blot-NBP2-54624-img0004.jpg "Western Blot: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Detection using 10 ug/ml Anti-CEACAM3/5 [308/3-3] followed by HRP-coupled secondary pAb. Visualized by chemiluminescence detection.")
![Flow Cytometry: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM3/5 [308/3-3] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Flow-Cytometry-NBP2-54624-img0002.jpg)
![Sandwich ELISA: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Solid phase was coated with 3 ug/ml Anti-CEA (Dako) binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM3/5 [308/3-3] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Sandwich-ELISA-NBP2-54624-img0001.jpg)
![Immunoprecipitation: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Immunoprecipitation utilizing 10 ug/ml Anti-CEACAM3/5 [308/3-3]. Detection of the sample using 5 ug/ml pAb Anti-CEA (Dako) followed by HRP-coupled secondary pAb. Visualized by chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Immunoprecipitation-NBP2-54624-img0003.jpg)
![Western Blot: CEACAM5/CD66e Antibody (COL-1) [NBP3-05766] - Western Blot: CEACAM5/CD66e Antibody (COL-1) - Western Blot analysis of human stomach lysate.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-COL-1-Western-Blot-NBP3-05766-img0002.jpg "Western Blot: CEACAM5/CD66e Antibody (COL-1) [NBP3-05766] - Western Blot: CEACAM5/CD66e Antibody (COL-1) - Western Blot analysis of human stomach lysate.")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (COL-1) [NBP3-05766] - Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (COL-1) - Formalin-fixed, paraffin-embedded human colon carcinoma.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-COL-1-Immunohistochemistry-Paraffin-NBP3-05766-img0001.jpg)
![N/A CEACAM5/CD66e [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_CEACAM5_DY4128_ELISA_2008.jpg "N/A CEACAM5/CD66e [Biotin]")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) [NBP2-33010] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-261-Immunohistochemistry-Paraffin-NBP2-33010-img0003.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) [NBP2-33010] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) [NBP2-33010] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-261-Immunohistochemistry-Paraffin-NBP2-33010-img0002.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (SPM584) [NBP2-33009] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (SPM584).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-SPM584-Immunohistochemistry-Paraffin-NBP2-33009-img0006.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (SPM584) [NBP2-33009] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (SPM584).")
